deVries Tina Marie 4
4 · RVL Pharmaceuticals plc · Filed Jan 26, 2022
Insider Transaction Report
Form 4
deVries Tina Marie
EVP, Research & Development
Transactions
- Tax Payment
Ordinary Shares
2022-01-24$1.13/sh−9,607$10,856→ 141,588 total
4 · RVL Pharmaceuticals plc · Filed Jan 26, 2022
Ordinary Shares